MedTrace Logo

Comparison of the Effectiveness of Mirror Therapy and Mirror Mode of Hand Robot in Stroke

NCT07435688 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-04-15

No results posted yet for this study

Summary

The goal of this clinical trial is to compare the effectiveness of conventional mirror therapy and robotic mirror mode training in promoting upper extremity motor recovery in adult patients with ischemic stroke during the early subacute phase. The main questions it aims to answer are:

Does mirror mode of a robotic hand device result in greater motor function recovery compared to conventional mirror therapy?

Are there differences between the groups in somatosensory improvement and gross motor skill outcomes?

Do both intervention modalities result in clinically significant improvements in motor and functional outcomes?

Researchers will compare a conventional mirror therapy group and a robotic-assisted mirror mode group to determine which provides more significant gains in motor function, somatosensory input, and functional use of the paretic arm.

Participants will:

Receive standard physiotherapy sessions for 6 weeks

Be randomly assigned to either mirror therapy or robotic mirror mode intervention

Be evaluated using Fugl-Meyer Assessment, ARAT, Box and Block Test, Wolf Motor Function Test and Tactile/proprioceptive sensory test using Fugl-Meyer Assessment Sensory subsection.

Conditions

  • Stroke, Ischemic
  • Stroke
  • CVA (Cerebrovascular Accident)

Interventions

DEVICE

Hand Robot Mirror Mode

Mirror mode of the hand robot group will mimic the movement of the unaffected arm. The robot will provide proprioceptive and visual feedback and make patient believe that the affected arm is moving.

DEVICE

Therapy Mirror

Patients in the mirror therapy group will glance at the reflection of their non-affected arm and fall into the illusion that their non-affected limb is moving. This is supposed to assist patients regain motor deficits by reducing non-use paralysis.

Sponsors & Collaborators

  • The Scientific and Technological Research Council of Turkey

    collaborator OTHER

  • Istanbul University - Cerrahpasa

    collaborator OTHER

  • Zeynep Lide Uz

    lead OTHER

Principal Investigators

  • Ela Tarakcı, 1 · Istanbul University- Cerrahapaşa

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-10
Primary Completion
2024-11-25
Completion
2024-12-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07435688 on ClinicalTrials.gov